Updated Jul 16, 2026
Daniels Eric Joseph has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Eric Joseph Daniels is a corporate executive currently serving as the Chief Development Officer at Kiora Pharmaceuticals Inc. His role involves overseeing the development of pharmaceutical products and strategies within the company.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-02 | KPRX | KIORA PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 929 | $1.95 | $2K |
| 2026-03-10 | KPRX | KIORA PHARMACEUTICALS INC | A — Grant or award | 6.5K | $0.00 | |
| 2026-03-06 | KPRX | KIORA PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 238 | $2.02 | $481 |
Eric Joseph Daniels is a corporate executive currently serving as the Chief Development Officer at Kiora Pharmaceuticals Inc. His role involves overseeing the development of pharmaceutical products and strategies within the company.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Daniels Eric Joseph profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.